Related Experiment Video
Updated: Sep 30, 2026

Using the Activity-based Anorexia Rodent Model to Study the Neurobiological Basis of Anorexia Nervosa
Published on: October 22, 2015
Effect of oral potassium supplementation on QT dispersion in anorexia nervosa
F Franzoni1, E Mataloni, R Femia
1Department of Internal Medicine, University of Pisa, Italy.
Unlabelled:
The aim of this study was to evaluate the degree of QT dispersion in a group of young women with anorexia nervosa and its changes after oral potassium supplementation. Twenty-eight patients with self-induced starvation were matched with 20 thin and 20 normal-weight women (body mass index > or = 20). All participants underwent a complete clinical examination, including electrocardiogram (ECG) for QT interval measurements. QT dispersion was defined as the difference between the longest and the shortest QT interval occurring in the 12-lead ECG. QT dispersion was corrected (QTc) with Bazett's formula. Anorexic patients were later allocated two subgroups of 14 to receive or not to receive potassium aspartate (2 vials K-Flebo d(-1) = 60 mEq d(-1), per os). ECG was repeated in both the subgroups of anorexic patients after 4 wk. QT dispersion was significantly greater in starving patients than in thin or normal-weight women (QT dispersion = 62.2 +/- 12.4 vs 33.4 +/- 7.1 or 31.7 +/- 6.3ms; QTc dispersion = 56.5 +/- 12 vs 34 +/- 9.1 or 33.2 +/- 11 ms, p < 0.001). After 4 wk, anorexic women treated with oral potassium aspartate supplementation, compared with untreated patients. showed an increased kalaemia (4.21 +/- 0.16 vs 3.91 +/- 0.32 mmol 1(-1), p < 0.05) and a significant reduction in the QT interval dispersion (QT dispersion = 44.2 +/- 8.1 vs 63.2 +/- 9.1 ms, QTc dispersion = 41.3 +/- 9.7 vs 57.4 +/- 9 ms, p < 0.001).
Conclusion:
Patients with anorexia nervosa have greater QT dispersion than constitutionally thin and normal-weight women, and oral potassium supplementation tends to reduce it. This suggests that the reduction in the pool of potassium may be the critical factor inducing the enhancement of the QT dispersion in anorexia nervosa.
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Dosage Regimens: Partial Pharmacokinetic Parameters
Ionic Strength: Effects on Chemical Equilibria
In this solution, the primary cation—the calcium...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
